Titan Biotech Limited Press Release Sep 29 2026
Filed with BSE · · 5 pages · English
Summary by 6ix AI
The meeting was conducted via video conferencing and included discussions on ordinary and special business matters. Key decisions included the adoption of financial statements, declaration of dividends, and re-appointments of directors. The document also notes that the results of the voting will be disclosed separately as required by regulations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Sep 10 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Sep 07 2026
- Titan Biotech Limited Press Release Sep 05 2026
- Notice Of Thirty- Fourth (34Th) Annual General Meeting
Later from Titan Biotech
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
- Titan Biotech Limited Press Release Sep 30 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement under Regulation 30 (LODR)-Allotment
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech